• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[医院获得性肺炎的管理——最新进展]

[Management of nosocomial pneumonia-state of the art].

作者信息

Welte T

机构信息

Abteilung Pneumologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover.

出版信息

Intensivmed Notfallmed. 2006;43(4):301-309. doi: 10.1007/s00390-006-0721-2.

DOI:10.1007/s00390-006-0721-2
PMID:32287633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7101873/
Abstract

Nosocomial pneumonia is among the most frequent infections in the intensive care unit with high morbidity and mortality. The decisive factor for treatment failure is inadequate previous antibiotic treatment. Broad spectrum and sufficiently high dosed initial treatment is crucial.To prevent further resistances, the antibiotic treatment must be evaluated early. Depending on the treatment success, treatment has to be changed or terminated. Deescalation is possible and sensible after three days. A treatment period of seven days should not routinely be exceeded. The treatment recommendations should be adapted to local resistances and the local statistics of frequent pathogens. A further factor for treatment decision-making is the risk analysis of the patient (previous treatment, stays in hospitals or nursing homes, concomitant diseases).

摘要

医院获得性肺炎是重症监护病房中最常见的感染之一,具有高发病率和死亡率。治疗失败的决定性因素是先前抗生素治疗不足。广谱且剂量足够高的初始治疗至关重要。为防止进一步产生耐药性,必须尽早评估抗生素治疗。根据治疗效果,必须更改或终止治疗。三天后进行降阶梯治疗是可行且合理的。治疗期通常不应超过七天。治疗建议应根据当地的耐药情况和常见病原体的当地统计数据进行调整。治疗决策的另一个因素是患者的风险分析(先前的治疗、住院或养老院停留情况、伴随疾病)。

相似文献

1
[Management of nosocomial pneumonia-state of the art].[医院获得性肺炎的管理——最新进展]
Intensivmed Notfallmed. 2006;43(4):301-309. doi: 10.1007/s00390-006-0721-2.
2
Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.成人重症监护病房中与肺炎相关的医院血流感染中的抗菌药物耐药性及系统性监测培养的价值
Crit Care Med. 2006 Mar;34(3):653-9. doi: 10.1097/01.CCM.0000201405.16525.34.
3
Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy.医院获得性肺炎和呼吸机相关性肺炎治疗管理方案的最新进展:现行指南及治疗的经济学方面综述
Infect Drug Resist. 2013 Dec 18;7:1-7. doi: 10.2147/IDR.S25985.
4
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.重症监护病房医院获得性肺炎的经验性广谱抗生素治疗:一项前瞻性观察研究。
Crit Care. 2006;10(3):R78. doi: 10.1186/cc4919. Epub 2006 May 16.
5
[Quality of care assessment and nosocomial pneumonia in the intensive care unit].[重症监护病房的护理质量评估与医院获得性肺炎]
Rev Mal Respir. 2006 Apr;23 Suppl 2:4S27-4S43.
6
Ventilator-associated pneumonia complicating the acute respiratory distress syndrome.呼吸机相关性肺炎并发急性呼吸窘迫综合征。
Semin Respir Crit Care Med. 2001 Jun;22(3):317-26. doi: 10.1055/s-2001-15788.
7
Current guidelines for the treatment of severe pneumonia and sepsis.重度肺炎和脓毒症的现行治疗指南。
Chemotherapy. 2005 Aug;51(5):227-33. doi: 10.1159/000087452.
8
Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study.外科患者医院获得性肺炎的诊断与治疗管理:风神研究结果
Crit Care Med. 2002 Feb;30(2):368-75. doi: 10.1097/00003246-200202000-00017.
9
Hospital-Acquired Pneumonia in a Multipurpose Intensive Care Unit: One-Year Prospective Study.多用途重症监护病房中医院获得性肺炎:一年期前瞻性研究
Acta Med Port. 2019 Dec 2;32(12):746-753. doi: 10.20344/amp.11607.
10
[Actualities of adults' ventilator-associated pneumonia].[成人呼吸机相关性肺炎的现状]
Medicina (Kaunas). 2006;42(2):91-7.

引用本文的文献

1
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.降钙素原指导重症监护患者抗生素治疗疗程:一项随机前瞻性对照试验
Crit Care. 2009;13(3):R83. doi: 10.1186/cc7903. Epub 2009 Jun 3.
2
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.降钙素原(PCT)指导下的方案可缩短外科重症监护病房严重脓毒症患者的抗生素治疗时间:一项前瞻性随机研究的结果
Langenbecks Arch Surg. 2009 Mar;394(2):221-6. doi: 10.1007/s00423-008-0432-1. Epub 2008 Nov 26.

本文引用的文献

1
[New antibiotics for treatment of MRSA infections. Comparison of treatment with vancomycin].
Med Monatsschr Pharm. 2006 Feb;29(2):56-62; quiz 63-4.
2
Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.侵袭性化脓性链球菌分离株中由于自发突变和水平基因转移导致的氟喹诺酮耐药性。
Antimicrob Agents Chemother. 2006 Mar;50(3):943-8. doi: 10.1128/AAC.50.3.943-948.2006.
3
The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.抗菌药物耐药性与患者预后之间的关系:死亡率、住院时间和医疗费用。
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9. doi: 10.1086/499406.
4
Do clinical findings in lower respiratory tract infection help general practitioners prescribe antibiotics appropriately? An observational cohort study in general practice.下呼吸道感染的临床检查结果能否帮助全科医生合理开具抗生素?一项全科医疗中的观察性队列研究。
Fam Pract. 2006 Apr;23(2):180-7. doi: 10.1093/fampra/cmi100. Epub 2005 Dec 2.
5
[S3-guideline on ambulant acquired pneumonia and deep airway infections].[S3 关于门诊获得性肺炎和深部气道感染的指南]
Pneumologie. 2005 Sep;59(9):612-64. doi: 10.1055/s-2005-870988.
6
Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria.早发性和晚发性呼吸机相关性肺炎主要由潜在的多重耐药菌引起。
Intensive Care Med. 2005 Nov;31(11):1488-94. doi: 10.1007/s00134-005-2697-y. Epub 2005 Sep 7.
7
Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides.用糖肽类药物治疗耐苯唑西林金黄色葡萄球菌引起的肺炎。
Crit Care Med. 2005 Sep;33(9):1983-7. doi: 10.1097/01.ccm.0000178180.61305.1d.
8
Aminoglycoside antibiotics induce bacterial biofilm formation.氨基糖苷类抗生素可诱导细菌生物膜形成。
Nature. 2005 Aug 25;436(7054):1171-5. doi: 10.1038/nature03912.
9
How many infections are caused by patient-to-patient transmission in intensive care units?重症监护病房中患者之间的传播会导致多少感染?
Crit Care Med. 2005 May;33(5):946-51. doi: 10.1097/01.ccm.0000163223.26234.56.
10
Escherichia coli: development of carbapenem resistance during therapy.大肠杆菌:治疗期间碳青霉烯类耐药性的产生
Clin Infect Dis. 2005 May 15;40(10):e84-6. doi: 10.1086/429822. Epub 2005 Apr 13.